425: Strive CFO Reposts Semler Scientific Merger Update

Strive's CFO reposted a communication regarding the proposed business combination with Semler Scientific, highlighting forward-looking statements and regulatory filing details.

Summary

• Ben Pham, Chief Financial Officer of Strive, Inc., reposted a communication on September 26, 2025, concerning Strive's proposed business combination with Semler Scientific, Inc.
• The communication contains forward-looking statements regarding the proposed transaction, including strategic and financial benefits, timing of closing, and integration success.
• It emphasizes that these forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when available, as they will contain important information.
• Details are provided on where to obtain these and other relevant SEC filings, including the SEC's website and the companies' respective investor relations channels.
• Strive, Semler Scientific, and certain directors, executive officers, and employees may be deemed participants in the solicitation of proxies for the proposed transaction.
• The communication clarifies that it does not constitute an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote or approval.

Sentiment

Score: 5

Explanation: The filing is a standard regulatory disclosure for a proposed business combination, primarily serving as a cautionary statement regarding forward-looking information and outlining numerous risks associated with the transaction and integration. It does not present new positive or negative operational results but rather details potential challenges and procedural steps.

Positives

• The proposed transaction is anticipated to yield strategic and financial benefits for the combined company.
• The combined company is expected to achieve successful integration of businesses.

Negatives

• The proposed transaction may not close as expected or at all due to unmet conditions.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies could be more difficult, time-consuming, or costly than expected.
• The transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Potential adverse reactions from customers or changes to business or employee relationships could occur.
• Changes in Strive's or Semler Scientific's share price may occur before closing.

Risks

• The occurrence of any event, change, or other circumstance that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The outlook and expectations for the proposed business combination between Strive and Semler Scientific include anticipated strategic and financial benefits, successful integration, and a projected timeline for closing. However, these forward-looking statements are subject to significant risks and uncertainties that could materially alter actual outcomes.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., reposted the communication on September 26, 2025, regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

This announcement relates to a proposed business combination, a common strategic move in various industries for growth or consolidation. The explicit mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that at least one of the companies, or the combined entity, has exposure to or plans to engage with the digital asset market, reflecting a growing trend in corporate finance and investment strategies.

Stakeholder Impact

• Shareholders: Potential for dilution from Strive's stock issuance, requirement to vote on the proposed merger, and urged to review detailed regulatory filings.
• Customers: Potential for adverse reactions or changes to existing business relationships due to the merger.
• Employees: Potential for changes to employee relationships as a result of the business combination.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

The filing is a cautionary statement regarding a proposed business combination, emphasizing numerous risks and uncertainties associated with the transaction, including the possibility of non-realization of anticipated benefits, integration difficulties, and shareholder dilution. While a merger can be transformative, the document highlights significant potential challenges. Investors should hold their positions and await further detailed information from the upcoming S-4 filing and the outcome of the shareholder vote before making definitive investment decisions.

Keywords

Merger, Acquisition, Business Combination, SEC Filing, Form 425, Strive, Semler Scientific, Forward-Looking Statements, Bitcoin, Digital Assets, Corporate Governance, Financial Reporting